Sanofi says it will pay up to $300M for AstraZeneca's rare thyroid cancer treatment Caprelsa
July 27, 2015 at 13:55 PM EDT
French drugmaker Sanofi said Monday it will pay up to $300 million to buy a thyroid cancer drug from British competitor AstraZeneca.
